578 related articles for article (PubMed ID: 25900655)
1. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.
Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P
mBio; 2015 Apr; 6(2):. PubMed ID: 25900655
[TBL] [Abstract][Full Text] [Related]
2. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P
Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134
[TBL] [Abstract][Full Text] [Related]
3. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.
Martín R; Chain F; Miquel S; Lu J; Gratadoux JJ; Sokol H; Verdu EF; Bercik P; Bermúdez-Humarán LG; Langella P
Inflamm Bowel Dis; 2014 Mar; 20(3):417-30. PubMed ID: 24418903
[TBL] [Abstract][Full Text] [Related]
4. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
Qiu X; Zhang M; Yang X; Hong N; Yu C
J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
[TBL] [Abstract][Full Text] [Related]
5. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492
[TBL] [Abstract][Full Text] [Related]
6. Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.
Rossi O; Khan MT; Schwarzer M; Hudcovic T; Srutkova D; Duncan SH; Stolte EH; Kozakova H; Flint HJ; Samsom JN; Harmsen HJ; Wells JM
PLoS One; 2015; 10(4):e0123013. PubMed ID: 25910186
[TBL] [Abstract][Full Text] [Related]
7. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis.
Zhou Y; Xu H; Xu J; Guo X; Zhao H; Chen Y; Zhou Y; Nie Y
AMB Express; 2021 Feb; 11(1):33. PubMed ID: 33641084
[TBL] [Abstract][Full Text] [Related]
8. Butyrate mediates anti-inflammatory effects of
Lenoir M; Martín R; Torres-Maravilla E; Chadi S; González-Dávila P; Sokol H; Langella P; Chain F; Bermúdez-Humarán LG
Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33054518
[TBL] [Abstract][Full Text] [Related]
9. Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3.
Zhang M; Zhou L; Wang Y; Dorfman RG; Tang D; Xu L; Pan Y; Zhou Q; Li Y; Yin Y; Zhao S; Wu J; Yu C
Int Immunol; 2019 Jul; 31(8):499-514. PubMed ID: 30809639
[TBL] [Abstract][Full Text] [Related]
10. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
11. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
[TBL] [Abstract][Full Text] [Related]
12. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.
Rossi O; van Berkel LA; Chain F; Tanweer Khan M; Taverne N; Sokol H; Duncan SH; Flint HJ; Harmsen HJ; Langella P; Samsom JN; Wells JM
Sci Rep; 2016 Jan; 6():18507. PubMed ID: 26725514
[TBL] [Abstract][Full Text] [Related]
13. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
[TBL] [Abstract][Full Text] [Related]
14. Expression of CCR6 and CXCR6 by Gut-Derived CD4
Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
[TBL] [Abstract][Full Text] [Related]
15. Administration of live, but not inactivated, Faecalibacterium prausnitzii has a preventive effect on dextran sodium sulfate‑induced colitis in mice.
Kawade Y; Sakai M; Okamori M; Morita M; Mizushima K; Ueda T; Takagi T; Naito Y; Itoh Y; Shimada T
Mol Med Rep; 2019 Jul; 20(1):25-32. PubMed ID: 31115531
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
17. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation.
Huang XL; Zhang X; Fei XY; Chen ZG; Hao YP; Zhang S; Zhang MM; Yu YQ; Yu CG
World J Gastroenterol; 2016 Jun; 22(22):5201-10. PubMed ID: 27298563
[TBL] [Abstract][Full Text] [Related]
18. Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats.
Zhang M; Qiu X; Zhang H; Yang X; Hong N; Yang Y; Chen H; Yu C
PLoS One; 2014; 9(10):e109146. PubMed ID: 25275569
[TBL] [Abstract][Full Text] [Related]
19. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.
Martín R; Miquel S; Chain F; Natividad JM; Jury J; Lu J; Sokol H; Theodorou V; Bercik P; Verdu EF; Langella P; Bermúdez-Humarán LG
BMC Microbiol; 2015 Mar; 15():67. PubMed ID: 25888448
[TBL] [Abstract][Full Text] [Related]
20. Co-Culture with
Kim H; Jeong Y; Kang S; You HJ; Ji GE
Microorganisms; 2020 May; 8(5):. PubMed ID: 32466189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
